Comparison of two first-line chemotherapy regimens( docetaxel plus capecitabine versus docetaxel plus epirubicine) for patients with metastatic breast cancer

ZHAO Wen-ying; YE Xiao-bing; CHEN Dong-yun; JI Zhao-ning

doi:10.3969/j.issn.1009-0460.2011.08.009

Home>Articles>Comparison of two first-line chemotherapy regimens( docetaxel plus capecitabine versus docetaxel plus epirubicine) for patients with metastatic breast cancer

DOI: 10.3969/j.issn.1009-0460.2011.08.009

Comparison of two first-line chemotherapy regimens( docetaxel plus capecitabine versus docetaxel plus epirubicine) for patients with metastatic breast cancer

ZHAO Wen-ying

YE Xiao-bing

CHEN Dong-yun

JI Zhao-ning

Machine-generated Keywords：

Publication Date：2011-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 705-708 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2011,16(8)